Announcing the Collaborative Drug Discovery Second Annual Community Meeting
The Second Annual CDD Community Meeting (a free, 1-day event) on October 7th is the best place for the CDD community and all scientists to get together, discuss their research projects, and showcase their work to others in the community. Training will be from 8-10AM and the conference from 10AM-6PM followed by a reception until 7PM. The Collaborative Drug Discovery Second Annual Community Meeting will be hosted at the J. David Gladstone Institutes’ 1st floor auditorium at 1650 Owens St. (UCSF), San Francisco, CA, see: http://qb3.org/cdd.htm
Early list of confirmed speakers:
- David Sullivan, MD, Johns Hopkins
- Fred Buckner, MD, University of Washington
- Janice Kranz, PhD, Stanley Center for Psychiatric Research, Broad Institute of MIT & Harvard
- Conor Caffrey, PhD, Sandler Center, UCSF
- Jean Claude-Bradley, PhD, Dept. of Chemistry, Drexel University
- Sean Ekins, PhD, ex-Pfizer/Lilly Computational Chemist
- Andrea Altieri, PhD, ASINEX
- Robert Damoiseaux, PhD, UCLA Molecular Screening Shared Resource (MSSR) Center & Anjali Jain, PhD, Cedars-Sinai
- Moses Hohman, PhD, Head of Software, Collaborative Drug Discovery (CDD roadmap)
- J. Leighton Read, MD (Alloy Ventures) – Financing Biomedical Innovation from academia to the market: From FluMist™ to Priority Review Vouchers and other stories
- Russell “Rusty” Bromley, Chief Operating Officer, Myelin Repair Foundation
Timely panel topics:
- Panel #1: What makes collaborations successful within and between groups?
Panelists: Adam Renslo (UCSF), Robert Damoiseaux (UCLA), Scott Lokey (UCSC)
- Panel #2: What are foundations looking for from academic researchers?
Panelists: Russell Bromley (COO, Myelin Repair Foundation), Leighton Read (Alloy Ventures), Victoria Hale (Founder, One World Health), Catherine Ley (Collabrx), Wells Whitney (Lung Cancer Foundation)
Who should attend?
- Scientists working in drug discovery
- Researchers who are involved in collaborations or generate complex drug discovery data
- Students who want to learn more about the drug discovery industry
- People who wish to network, establish new or strengthen existing collaborations
- Current CDD community members to set the collaborative platform’s future direction
- Anyone interested in new drugs for diseases of the developing world, private public partnerships, and/or global health
Thanks to our co-sponsors:
- Assay Depot
Interested parties should register now. We will also be having a post-symposium reception from 6 -7pm.